Virpax Pharmaceuticals

VRPX · NASDAQ

$0.0008−$0.0002 (−20.00%)TodayMarket closed · Oct 20, 2:01 PM ET

No price history for this range.

Latest news

NewsApr 3, 1:06 PM ET
11 Health Care Stocks Moving In Thursday's Intraday Session
NewsMar 20, 5:53 AM ETRishabh Mishra
US Stocks Likely To Open Lower After Fed Decision: Any Pullback In Equities 'Offers An Opportunity,' Says Expert
Press releaseMar 19, 8:00 AM ETBusiness Wire
Virpax Pharmaceuticals Announces Reverse Stock Split
NewsMar 18, 5:05 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
Press releaseMar 18, 4:01 PM ETBusiness Wire
Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in IND
NewsMar 18, 1:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsMar 18, 8:07 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsMar 18, 6:04 AM ETAvi Kapoor
Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
NewsMar 17, 5:05 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
Press releaseMar 7, 8:00 AM ETBusiness Wire
Virpax Looking to Use MET to Develop Intranasal COVID Vaccine
Press releaseMar 5, 4:01 PM ETBusiness Wire
Virpax's NES100 to be Presented at The Society of Toxicology by NCATS
NewsFeb 28, 6:00 AM ETRishabh Mishra
US Stocks Likely To Open Higher Following A Sell-Off, 'This Choppy Start To 2025 Isn't Abnormal. Don't Panic,' Says Expert Highlighting Seasonal Weakness In The First Quarter After Elections
Press releaseFeb 27, 4:01 PM ETBusiness Wire
Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology
NewsFeb 18, 7:05 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsFeb 14, 4:05 PM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
Press releaseFeb 13, 4:01 PM ETBusiness Wire
Virpax Confirms Positive Results with US Army with Probudur™ for Combat Care Study
Press releaseJan 31, 8:30 AM ETBusiness Wire
Virpax's Matthew Barnes to Present at Outsourcing in Clinical Trials Conference
Press releaseJan 30, 9:23 AM ETBusiness Wire
Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Press releaseJan 28, 9:15 AM ETBusiness Wire
Virpax Pharmaceuticals, Inc. Announces Pricing of $6 Million Public Offering of Common Stock and Pre-Funded Warrants
NewsDec 6, 5:22 AM ETAvi Kapoor
Why DocuSign Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
NewsNov 25, 4:05 PM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
Press releaseNov 22, 8:30 AM ETBusiness Wire
Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™
Press releaseNov 21, 4:05 PM ETBusiness Wire
Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative
NewsNov 18, 4:05 PM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
Press releaseNov 15, 4:09 PM ETBusiness Wire
Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
NewsNov 13, 4:05 PM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Press releaseNov 13, 9:15 AM ETBusiness Wire
Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Press releaseNov 5, 8:30 AM ETGlobe Newswire
Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer
NewsOct 17, 8:10 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press releaseAug 13, 7:30 AM ETBusiness Wire
Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments
Press releaseAug 8, 7:30 AM ETBusiness Wire
Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15
Press releaseJul 24, 7:30 AM ETBusiness Wire
Virpax Regains Compliance with Nasdaq Minimum Bid Price
NewsJul 19, 1:24 PM ETAvi Kapoor
Why Selective Insurance Group Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
NewsJul 19, 10:01 AM ETAvi Kapoor
Dow Tumbles Over 100 Points; American Express Earnings Beat Views
NewsJul 17, 1:28 PM ETAvi Kapoor
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

11 Health Care Stocks Moving In Thursday's Intraday Session

US Stocks Likely To Open Lower After Fed Decision: Any Pullback In Equities 'Offers An Opportunity,' Says Expert

Virpax Pharmaceuticals Announces Reverse Stock Split

12 Health Care Stocks Moving In Tuesday's After-Market Session

Virpax Receives Positive Probudur™ Results for Dose Range Study Moves Towards Next Steps in IND

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Monday's After-Market Session

Virpax Looking to Use MET to Develop Intranasal COVID Vaccine

Virpax's NES100 to be Presented at The Society of Toxicology by NCATS

US Stocks Likely To Open Higher Following A Sell-Off, 'This Choppy Start To 2025 Isn't Abnormal. Don't Panic,' Says Expert Highlighting Seasonal Weakness In The First Quarter After Elections

Virpax Reports Positive Results in Human Study for its Molecular Envelope Technology

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

Virpax Confirms Positive Results with US Army with Probudur™ for Combat Care Study

Virpax's Matthew Barnes to Present at Outsourcing in Clinical Trials Conference

Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Virpax Pharmaceuticals, Inc. Announces Pricing of $6 Million Public Offering of Common Stock and Pre-Funded Warrants

Why DocuSign Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Monday's Pre-Market Session

Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™

Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative

12 Health Care Stocks Moving In Monday's Pre-Market Session

Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments

Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15

Virpax Regains Compliance with Nasdaq Minimum Bid Price

Why Selective Insurance Group Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Dow Tumbles Over 100 Points; American Express Earnings Beat Views

Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session